GlaxoSmithKline (GSK)

 
 

Share Price

Bid Price High Price
Ask Price Low Price
Open Price Spread
Prev Close Volume

GlaxoSmithKline Historic Prices

Date Open High Low Close Volume
Jan 16, 2018 1,356.60 1,360.80 1,349.20 1,355.00 11,776,369
Jan 15, 2018 1,350.60 1,355.60 1,340.60 1,353.00 7,512,929
Jan 12, 2018 1,342.80 1,358.40 1,336.40 1,353.00 14,690,146
Jan 11, 2018 1,336.00 1,342.00 1,327.80 1,330.60 10,758,751
Jan 10, 2018 1,341.80 1,347.00 1,320.20 1,331.00 16,587,925
More GlaxoSmithKline Historic Prices >
Intraday
Historic - 1 year
Advanced GlaxoSmithKline Charts >

GlaxoSmithKline Share Information

Company Name GlaxoSmithKline Epic GSK
ISIN GB0009252882 Index FTSE 100
EMS 1,500 Prev Close 1,359.20
Shares in Issue (m) 4,957.95 Market Cap (£m) 67,180.19
PE Ratio 72.07 Div per Share (p) 80.00
Div Yield 5.90 Div Cover 0.24
EPS 18.80 EPS Growth (%) -89.21
PEG -0.81 DPS Growth (%) 0.00
ROCE 4.84 Net Gearing 83.31
Quick Ratio 0.61 Current Ratio 0.88

GlaxoSmithKline Broker Views

Date Broker Recomm. Price Old Target New Target Notes
17 Jan Barclays Capital Overweight 1,359.20 1,450.00 1,650.00 Upgrades
16 Jan Jefferies International Buy 1,359.20 - 1,500.00 Reiterates
16 Jan Exane BNP Paribas Neutral 1,359.20 - 1,580.00 Reiterates
15 Jan Liberum Capital Buy 1,359.20 1,760.00 1,760.00 Reiterates
11 Jan Deutsche Bank Hold 1,359.20 1,380.00 1,440.00 Reiterates
More GlaxoSmithKline Broker Views >

GlaxoSmithKline Director Deals

Date Director Type Volume / Price Trade Value
16 Jan 2018 Emma Walmsley Dividend Reinvestment 1,085 @ 13,306.00p £144,370.10
15 Jan 2018 Simon Dingemans Dividend Reinvestment 920 @ 1,334.40p £12,276.48
15 Jan 2018 Emma Walmsley Dividend Reinvestment 473 @ 1,334.40p £6,311.71
15 Jan 2018 Dr Patrick Vallance Dividend Reinvestment 2,918 @ 1,334.40p £38,937.79
18 Dec 2017 Dr Patrick Vallance Sell 52,974 @ 1,309.78p £693,840.21
More GlaxoSmithKline Director Deals >

GlaxoSmithKline Events

Date Event Type
10 Aug 2017 Ex-Dividend
25 Oct 2017 Interim Result
09 Nov 2017 Ex-Dividend
07 Feb 2018 Trading Statement
07 Feb 2018 Final Result
More GlaxoSmithKline events >

GlaxoSmithKline News